Industry Developments

BMI View: Our view that Ukraine's pharmaceutical market will continue to return double-digit growth rates into 2011 has been confirmed. In fact, stronger than expected growth rates... 2011-08-02

BMI View: While drugmakers based in developed countries are increasingly targeting emerging markets, Pharmstandard's primary exposure to Russia will enable it to exploit strong domestic... 2011-07-29

BMI View: We view Indian drugmaker JB Chemicals & Pharmaceuticals (JBCPL)'s strategy - to sell its Russian and Commonwealth of Independent States (CIS) over-the-counter (OTC) brands... 2011-07-26

BMI View: As a leading representative of the Russian pharmaceutical industry, the view of the Association of Russian Pharmaceutical Manufacturers (ARPM) offers an insight into regulatory... 2011-07-18

BMI View: These are difficult times for pharmacy retail in Russia, but there were signs of recovery in the early part of 2011. We see increasing upside potential from pharmacy chain... 2011-07-15

BMI View: Our cautiously optimistic growth projections for Turkey's pharmaceutical market in 2011 have been validated for first five months of the year by a combination of local production... 2011-07-14

BMI View: Highlighting the economic and political challenges faced by Belarus's domestic pharmaceutical industry, it has now emerged that government is seeking to restructure Belbiopharm... 2011-07-13

BMI View: While further drug price reductions are indeed damaging to the attractiveness of the Greek pharmaceutical market, the reductions remain within BMI's forecast scenario for... 2011-07-12

BMI View: While the Russian government has made substantial resources available for the improvement of the country's healthcare provision, recent legislative reforms have been criticised... 2011-07-11

BMI View: Our equity view of Slovenian company Krka remains neutral, but with some upside potential since our previous analysis. Despite the company's exposure to high-growth pharmaceutical... 2011-07-08